Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/1/2018
SIETES contiene 92186 citas

 
 
 1 a 20 de 968 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 2017;84:1. [Ref.ID 102184]
2. Cita con resumen
Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V. Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. Br J Clin Pharmacol 2017;83:2572-80. [Ref.ID 102117]
4. Cita con resumen
Chang S-H, Chou I-J, Yeh Y-H, Chiou M-J, Wen M-S, Kuo C-T, See L-C, Kuo C-F. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 2017;318:1250-9. [Ref.ID 102073]
5. Cita con resumen
Hammann F, Gotta V, Conen K, Medinger M, Cesana P, Rochlitz C, Taegtmeyer AB. Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity. Br J Clin Pharmacol 2017;83:927-30. [Ref.ID 101972]
6.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
7. Cita con resumen
Anónimo. FDA approves Epclusa for treatment of chronic hepatitis C virus infection. FDA U.S. Food and Drug Administration 2016:28 de junio. [Ref.ID 100447]
8. Cita con resumen
Anónimo. Loperamide (Imodium): Drug Safety Communication - Serious heart problems with high doses from abuse and misuse. FDA U.S. Food and Drug Administration 2016:7 de junio. [Ref.ID 100377]
9. Cita con resumen
Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]
10.Enlace a cita original Cita con resumen
Anónimo. Riesgos de los fármacos anticolinérgicos en personas de edad avanzada. Butlletí Groc 2015;28:1-4. [Ref.ID 99838]
11. Cita con resumen
Macle L, Khairy P, Weerasooriya R, Novak P, Verma A, Willems S, Arentz T, Deisenhofer I, Veenhuyzen G, Scavée C, Jaïs P, Puererfellner H, Levesque S, Andrade JG, Rivard L, Guerra PG, Dubuc M, Thibault B, Talajic M, Roy D, Nattel S, ADVICE trial investigators. Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet 2015;386:672-9. [Ref.ID 99493]
13.Tiene citas relacionadas
Moss JD, Cifu AS. Management of anticoagulation in patients with atrial fibrillation. JAMA 2015;314:291-2. [Ref.ID 99362]
14.Tiene citas relacionadas
Prystowsky EN, Padanilam BJ, Fogel RI. Treatment of atrial fibrillation. JAMA 2015;314:278-88. [Ref.ID 99361]
15. Cita con resumen
Alonso A, MacLehose RF, Lutsey PL, Konety S, Chen LY. Association of amiodarone use with acute pancreatitis in patients with atrial fibrillation: a nested case-control study. JAMA Intern Med 2015;175:449-50. [Ref.ID 98967]
16.Tiene citas relacionadas
Campbell NL, Boustani MA. Adverse cognitive effects of medications: turning attention to reversibility. JAMA Intern Med 2015;175:408-9. [Ref.ID 98843]
17.Tiene citas relacionadas Cita con resumen
Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Krane PK, Larson EB. Cumulative use of strong anticholinergics and incident dementia. A prospective cohort study. JAMA Intern Med 2015;175:401-7. [Ref.ID 98842]
18.Tiene citas relacionadas Cita con resumen
Gupta-Wright A, Lavers J, Irvine S. Concerns about the off-licence use of amiodarone for Ebola. BMJ 2015;350:h272. [Ref.ID 98715]
19.Tiene citas relacionadas Cita con resumen
Turone F. Doctors trial amiodarone for Ebola in Sierra Leone. BMJ 2014;349:g7198. [Ref.ID 98441]
20. Cita con resumen
Viles-Gonzalez JF, Halperin JL. Efficacy and safety of amiodarone in patients with atrial fibrillation in the era of target-specific anticoagulants. J Am Coll Cardiol 2014;64:1551-3. [Ref.ID 98230]
Seleccionar todas
 
 1 a 20 de 968 siguiente >>